CD63 and colorectal carcinoma: A number of EV membrane proteins, including CD147/basigin and EpCAM, have been selected to pair with the EV markers CD9 or CD63 as biomarker panels for CRC and have been successfully tested for effective cancer detection using blood specimens [40,41].